Linda Yaccarino Becomes CEO of Health Tech Startup eMed
Former X CEO Linda Yaccarino joins eMed to lead its GLP-1 health tech innovation journey.
Matilda
Linda Yaccarino Becomes CEO of Health Tech Startup eMed Linda Yaccarino Joins eMed as CEO: A Strategic Shift into Health Tech Linda Yaccarino joins eMed as CEO, marking a bold pivot from media leadership to the rapidly evolving world of health tech. Her transition comes shortly after her two-year stint as the chief executive at X, where she focused on stabilizing ad revenue amid ongoing platform controversies. Despite having no formal background in healthcare, Yaccarino’s appointment is making headlines—raising questions about how her unique experience in media, advertising, and executive management will shape eMed’s future. With eMed transitioning from COVID-related tools to GLP-1 therapies for chronic conditions like obesity and type II diabetes, the company is betting big on her leadership to accelerate its next phase of growth. Image Credits:Jerod Harris/Getty Images for Vox Media Why Linda Yaccarino Joins eMed at a Critical Juncture Yaccarino’s move into eMed is more than just a career change—it’s a strategic alignment. Her reputation for…